AAP
HZNP

Arax Advisory Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Arax Advisory Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-89
Closed -$10.3K – 1456
2023
Q3 		$10.3K Buy
89
+30
+51% +$3.22K ﹤0.01% 713
2023
Q2 		$6.07K Buy
59
+14
+31% +$1.48K ﹤0.01% 821
2023
Q1 		$4.91K Sell
45
-2
-4% -$221 ﹤0.01% 853
2022
Q4 		$5.35K Buy
47
+31
+194% +$2.58K ﹤0.01% 782
2022
Q3 		$1K Sell
16
-9
-36% -$629 ﹤0.01% 1204
2022
Q2 		$2K Sell
25
-21
-46% -$1.99K ﹤0.01% 992
2022
Q1 		$5K Buy
46
+39
+557% +$3.8K ﹤0.01% 807
2021
Q4 		$1K Hold
7
– – ﹤0.01% 1134
2021
Q3 		$1K Buy
+7
New +$727 ﹤0.01% 982

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return